Boston Scientific Corporation Stock News

Here is how Boston Scientific (BSX) and Cardinal Health (CAH) have performed compared to their sector so far this year.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis.

Reported and organic revenues at each of Boston Scientific's (BSX) core business segments and geographies increase in the reported quarter.

The headline numbers for Boston Scientific (BSX) give insight into how the company performed in the quarter ended March 2023, but it may be worthwhile to compare some of its key metrics to Wall Street

Boston Scientific (BSX) came out with quarterly earnings of $0.47 per share, beating the Zacks Consensus Estimate of $0.43 per share. This compares to earnings of $0.39 per share a year ago.

Boston Scientific reported better-than-expected first-quarter growth on Tuesday, pushing BSX stock closer to a profit-taking zone. The post Boston Scientific Approaches A Profit-Taking Zone On First-Q

Boston Scientific (NYSE:BSX) has reported first-quarter revenue and earnings that beat its own guidance as well as Wall Street's expectations due to strong growth at its MedSurg and Cardiovascular uni

Shares of Boston Scientific Corp. BSX jumped 2.8% into record territory in premarket trading Wednesday, after the medical technology company reported first-quarter results that beat expectations and r

A rise in elective surgeries performed and market share gains for some of its products will likely aid the company's top-line growth.

Boston Scientific is considering a takeover of Shockwave Medical, according to a report Friday that sent SWAV stock soaring. The post Shockwave Rockets As Boston Scientific Reportedly Mulls A Takeover

Investors are optimistic about Boston Scientific (BSX) owing to impressive growth in MedSurg market share.

The healthcare sector has been looking fit in the past month, with medical products makers Stryker Corp. (NYSE: SYK) and Boston Scientific Corp. (NYSE: BSX) rallying to all-time highs, while sector pe

Boston Scientific (BSX) outperforms the industry and the S&P 500 due to several new acquisitions and the long-term growth prospects of the WATCHMAN device.

MARLBOROUGH, Mass. , April 3, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the first quarter

“XLV” – the Health Care Select Sector SPDR Fund has been a disappointment for investors since the start of the year but a portfolio manager says it'll likely be a different story moving forward.